Stereotaxis (STXS, Financial) is gearing up to present a live demonstration of its groundbreaking GenesisX Robotic System during the upcoming Heart Rhythm Symposium (HRS) in San Diego, from April 24 to April 27. This event marks the public debut of GenesisX, offering attendees an exclusive look at its innovative clinical functions.
GenesisX represents a significant advancement in endovascular surgical robotics, enhancing the well-established Robotic Magnetic Navigation technology. Notably, the system is designed with a compact footprint, integrating magnetic shielding directly into its structure. This eliminates the necessity for additional room-based shielding, thereby reducing infrastructure burdens and improving accessibility for healthcare facilities.
The demonstration is expected to highlight the system’s versatility, showcasing its promise to revolutionize surgical procedures with its cutting-edge features. The 'weekend' installation capability further underscores the system's user-friendly nature, allowing for rapid integration into clinical settings.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for Stereotaxis Inc (STXS, Financial) is $4.50 with a high estimate of $5.00 and a low estimate of $4.00. The average target implies an upside of 143.24% from the current price of $1.85. More detailed estimate data can be found on the Stereotaxis Inc (STXS) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, Stereotaxis Inc's (STXS, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Stereotaxis Inc (STXS, Financial) in one year is $2.61, suggesting a upside of 41.08% from the current price of $1.85. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Stereotaxis Inc (STXS) Summary page.
